Chenao Qian

872 total citations
15 papers, 647 citations indexed

About

Chenao Qian is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Chenao Qian has authored 15 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Hematology and 5 papers in Cancer Research. Recurrent topics in Chenao Qian's work include Multiple Myeloma Research and Treatments (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Chenao Qian is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Chenao Qian collaborates with scholars based in China, United States and Germany. Chenao Qian's co-authors include Wenzhuo Zhuang, Bing-Zong Li, Sha Song, Huiying Han, Hongxia Xu, Wenqi Zhou, Hatice U. Osmanbeyoglu, Christopher J. Bakkenist, Tatiana N. Moiseeva and Norie Sugitani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Blood.

In The Last Decade

Chenao Qian

14 papers receiving 644 citations

Peers

Chenao Qian

ONCOL

HEMAT

Srikanth Talluri United States

Alex Murison Canada

Joydeep Bhadury Sweden

Scott Chartrand United States

Su Ming Sun Netherlands

Margaret Bell United Kingdom

David Brocks Germany

Andrew Volk United States

Changju Qu China

Nasrin Rastgoo Canada

Srikanth Talluri United States

Chenao Qian

503 ×0.9

211 ×0.8

242 ×1.8

ONCOL

96 ×0.9

HEMAT

52 ×1.2

Citations per year, relative to Chenao Qian Chenao Qian (= 1×) peers Srikanth Talluri

Countries citing papers authored by Chenao Qian

Since Specialization

Citations

This map shows the geographic impact of Chenao Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenao Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenao Qian more than expected).

Fields of papers citing papers by Chenao Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenao Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenao Qian. The network helps show where Chenao Qian may publish in the future.

Co-authorship network of co-authors of Chenao Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Chenao Qian. A scholar is included among the top collaborators of Chenao Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenao Qian. Chenao Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Qian, Chenao, Payman Zamani, Qasim Jehangir, et al.. (2022). Abstract 11642: Biologic Associations of the Senescence-Associated Secretory Phenotype (SASP) in Heart Failure (HF): Insights From Plasma Proteomics. Circulation. 146(Suppl_1). 1 indexed citations

Qian, Chenao, Jordana B. Cohen, Qasim Jehangir, et al.. (2022). Abstract 12661: Prognostic Significance of Tubular Injury Biomarkers in Heart Failure With Preserved Ejection Fraction (HFpEF). Circulation. 146(Suppl_1). 1 indexed citations

Song, Sha, Fan Gao, Qi Li, et al.. (2021). IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma. Oncogene. 40(35). 5393–5402. 28 indexed citations

Song, Sha, Ji Zhang, Qi Su, et al.. (2021). Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia. British Journal of Cancer. 124(11). 1843–1853. 14 indexed citations

Han, Huiying, Fan Gao, Sha Song, et al.. (2020). piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL. Blood. 137(12). 1603–1614. 136 indexed citations

Xu, Hongxia, Huiying Han, Sha Song, et al.. (2019). Exosome-Transmitted PSMA3 and PSMA3-AS1 Promote Proteasome Inhibitor Resistance in Multiple Myeloma. Clinical Cancer Research. 25(6). 1923–1935. 106 indexed citations

Moiseeva, Tatiana N., Yandong Yin, Michael Calderon, et al.. (2019). An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication. Proceedings of the National Academy of Sciences. 116(27). 13374–13383. 95 indexed citations

Moiseeva, Tatiana N., Chenao Qian, Norie Sugitani, Hatice U. Osmanbeyoglu, & Christopher J. Bakkenist. (2019). WEE1 kinase inhibitor AZD1775 induces CDK1 kinase-dependent origin firing in unperturbed G1- and S-phase cells. Proceedings of the National Academy of Sciences. 116(48). 23891–23893. 60 indexed citations

Li, Bing-Zong, Huiying Han, Sha Song, et al.. (2018). HOXC10 Regulates Osteogenesis of Mesenchymal Stromal Cells Through Interaction with Its Natural Antisense Transcript lncHOXC-AS3. Stem Cells. 37(2). 247–256. 32 indexed citations

10.

Li, Bing-Zong, Hongxia Xu, Huiying Han, et al.. (2018). Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene. 37(41). 5508–5519. 122 indexed citations

11.

Song, Sha, Huiying Han, Hongxia Xu, et al.. (2018). Potent Activity of the Bromodomain Inhibitor OTX015 in Multiple Myeloma. Molecular Pharmaceutics. 15(9). 4139–4147. 20 indexed citations

12.

Zhuang, Wenzhuo, Sha Song, Huiying Han, et al.. (2018). Exosome-Transmitted PSMA3 and PSMA3-AS1 Promotes Proteasome Inhibitors Resistance in Multiple Myeloma. Blood. 132(Supplement 1). 4434–4434.

13.

Gu, Jie, Sha Song, Huiying Han, et al.. (2018). The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple Myeloma. Molecular Pharmaceutics. 15(11). 5387–5396. 11 indexed citations

14.

Li, Bing-Zong, Huiying Han, Sha Song, et al.. (2018). Pirna-30473 Contributes to Tumorigenesis By Regulating RNA m6A Methylation in DLBCL. Blood. 132(Supplement 1). 2835–2835. 2 indexed citations

15.

Tang, Zaixiang, Yueping Shen, Xinyan Zhang, et al.. (2017). Group spike-and-slab lasso generalized linear models for disease prediction and associated genes detection by incorporating pathway information. Bioinformatics. 34(6). 901–910. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact